Hemoglobin alpha regulates T-lymphocyte activation and mitochondrial function
We have recently discovered hemoglobin alpha a1 (Hbα-a1 mRNA and Hbα protein) in T-lymphocytes and previously reported that its expression was sensitive to mitochondrial redox perturbations. However, outside of its occurrence and basic characterization, the functional role of Hbα in T-lymphocytes remained unknown. Herein, we identify Hbα in both CD4<sup>+</sup> and CD8<sup>+</sup> T-lymphocyte subsets, and found its expression is highly dynamic, differs between the two subtypes, and is dependent upon activation stage. Further, the loss of Hbα by use of a novel T-lymphocyte-specific Hbα knock-out mouse impairs mitochondrial function, dysregulates cytokine production, and lowers the activation threshold primarily in CD4<sup>+</sup> T-lymphocytes, indicating a critical role for Hbα within this subset. While these data suggested the loss of Hbα in T-lymphocytes may promote aberrant activation of autoreactive T-lymphocytes, surprisingly, we discovered that mice lacking Hbα in T-lymphocytes exhibited reduced severity of experimental autoimmune encephalomyelitis (EAE) compared to wild-type control animals. Interestingly, T-lymphocytes lacking Hbα <i>in vivo</i> appeared to function identically to wild-type controls, which did not explain the protection against EAE. In contrast, T-lymphocyte Hbα knock-out mice displayed significantly reduced levels of circulating immunoglobulins and CD40L expression compared to their wild-type counterparts during EAE, suggesting possible impaired intercellular communication. These data elucidate a previously unrecognized role for Hbα in T-lymphocyte function, which may have implications for hemoglobin-related diseases (i.e., hemoglobinopathies).
Authors
- Adam J. Case
- Tamara Natour (ORCID: https://orcid.org/0009-0005-1084-464X)
- Caroline N Jojo
- Emily Reed
- Sreeram Pasupuleti
- Lauren J. Pitts
- Tatlock H. Lauten
- Brooke L. Griffin
Institutions
- Texas A&M Health Science Center (US)
- Bryan College (US)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2026-01-08
- DOI
- https://doi.org/10.3389/fimmu.2025.1725904
- Primary Topic
- Hemoglobinopathies and Related Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institutes of Health